US FDA grants priority voucher to J&J's blood cancer treatment
- - US FDA grants priority voucher to J&J's blood cancer treatment
ReutersDecember 16, 2025 at 2:39 AM
0
A Johnson & Johnson banner is displayed on the front of the New York Stock Exchange (NYSE) in New York City, in New York City, U.S., December 5, 2023. REUTERS/Brendan McDermid
(Removes an extraneous word from paragraph 1)
Dec 15 (Reuters) - The U.S. Food and Drug Administration said on Monday it has granted a national priority voucher to Johnson & Johnson's treatment for a type of blood cancer, bringing the total number of products receiving an award under the program to 16 this year.
(Reporting by Christy Santhosh in Bengaluru)
Source: “AOL Breaking”
